In this double-blind , @-period , crossover trial , healthy adults ( n = @ ) received immediaterelease guanfacine ( at therapeutic ( @ mg ) and supra-therapeutic ( @ mg ) doses ) , placebo , and @ mg moxifloxacin ( positive control ) in @ of @ randomly assigned sequences .